271 related articles for article (PubMed ID: 8337509)
1. [Potential role of ATP-sensitive K+ channels in ischemia- and reperfusion-induced arrhythmias].
Nakaya H
Kokyu To Junkan; 1993 Jun; 41(6):512-20. PubMed ID: 8337509
[No Abstract] [Full Text] [Related]
2. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
Tosaki A; Szerdahelyi P; Engelman RM; Das DK
J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
[TBL] [Abstract][Full Text] [Related]
3. The ATP-regulated potassium channel in ischemia-reperfusion injury.
Gross GJ; Yao Z; Pieper GM; Auchampach JA
Ann N Y Acad Sci; 1994 Jun; 723():71-81. PubMed ID: 8030926
[No Abstract] [Full Text] [Related]
4. [Advance in pharmacology of potassium channels in cardiovascular system and their clinical use].
Wu Y; Fang D
Zhonghua Yi Xue Za Zhi; 1992 Mar; 72(3):180-3. PubMed ID: 1319810
[No Abstract] [Full Text] [Related]
5. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
Tosaki A; Engelman DT; Engelman RM; Das DK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
[TBL] [Abstract][Full Text] [Related]
6. Proarrhythmic effects of pinacidil are partially mediated through enhancement of catecholamine release in isolated perfused guinea-pig hearts.
D'Alonzo AJ; Zhu JL; Darbenzio RB; Dorso CR; Grover GJ
J Mol Cell Cardiol; 1998 Feb; 30(2):415-23. PubMed ID: 9515018
[TBL] [Abstract][Full Text] [Related]
7. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
Grover GJ; McCullough JR; Henry DE; Conder ML; Sleph PG
J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
[TBL] [Abstract][Full Text] [Related]
8. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells.
Satoh H
J Cardiovasc Pharmacol; 1993 Dec; 22(6):863-8. PubMed ID: 7509906
[TBL] [Abstract][Full Text] [Related]
9. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
Grover GJ; D'Alonzo AJ; Hess T; Sleph PG; Darbenzio RB
Cardiovasc Res; 1995 Nov; 30(5):731-8. PubMed ID: 8595620
[TBL] [Abstract][Full Text] [Related]
10. Pinacidil but not nicorandil opens ATP-sensitive K+ channels and protects against simulated ischemia in rabbit myocytes.
Critz SD; Liu GS; Chujo M; Downey JM
J Mol Cell Cardiol; 1997 Apr; 29(4):1123-30. PubMed ID: 9160864
[TBL] [Abstract][Full Text] [Related]
11. Essential role of nucleotide diphosphates in nicorandil-mediated activation of cardiac ATP-sensitive K+ channel. A comparison with pinacidil and lemakalim.
Shen WK; Tung RT; Machulda MM; Kurachi Y
Circ Res; 1991 Oct; 69(4):1152-8. PubMed ID: 1834361
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological evidence for the persistent activation of ATP-sensitive K+ channels in early phase of reperfusion and its protective role against myocardial stunning.
Shigematsu S; Sato T; Abe T; Saikawa T; Sakata T; Arita M
Circulation; 1995 Oct; 92(8):2266-75. PubMed ID: 7554211
[TBL] [Abstract][Full Text] [Related]
13. Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts.
Wolleben CD; Sanguinetti MC; Siegl PK
J Mol Cell Cardiol; 1989 Aug; 21(8):783-8. PubMed ID: 2506353
[TBL] [Abstract][Full Text] [Related]
14. Effects of putative activators of K+ channels in mouse pancreatic beta-cells.
Garrino MG; Plant TD; Henquin JC
Br J Pharmacol; 1989 Nov; 98(3):957-65. PubMed ID: 2531623
[TBL] [Abstract][Full Text] [Related]
15. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil.
Longman SD; Clapham JC; Wilson C; Hamilton TC
J Cardiovasc Pharmacol; 1988; 12(5):535-42. PubMed ID: 2468052
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia.
Grover GJ
J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S18-27. PubMed ID: 7898104
[TBL] [Abstract][Full Text] [Related]
18. KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.
Baczkó I; Leprán I; Papp JG
Eur J Pharmacol; 1997 Apr; 324(1):77-83. PubMed ID: 9137916
[TBL] [Abstract][Full Text] [Related]
19. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
Tosaki A; Hellegouarch A
J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
[TBL] [Abstract][Full Text] [Related]
20. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
